Literature DB >> 8975900

Immunoglobulin E, a pathogenic factor in Plasmodium falciparum malaria.

P Perlmann1, H Perlmann, B W Flyg, M Hagstedt, G Elghazali, S Worku, V Fernandez, A S Rutta, M Troye-Blomberg.   

Abstract

Most children and adults living in areas where the endemicity of Plasmodium falciparum malaria is high have significantly elevated levels of both total immunoglobulin E (IgE) and IgE antimalarial antibodies in blood. This elevation is highest in patients with cerebral malaria, suggesting a pathogenic role for this immunoglobulin isotype. In this study, we show that IgE elevation may also be seen in severe malaria without cerebral involvement and parallels an elevation of tumor necrosis factor alpha (TNF). IgE-containing serum from malaria immune donors was added to tissue culture plates coated with rabbit anti-human IgE antibodies or with P. falciparum antigen. IgE-anti-IgE complexes as well as antigen-binding IgE antibodies induced TNF release from peripheral blood mononuclear cells (PBMC). Nonmalaria control sera with no IgE elevation induced significantly less of this cytokine, and the TNF-inducing capacity of malaria sera was also strongly reduced by passing them over anti-IgE Sepharose columns. The cells giving rise to TNF were adherent PBMC. The release of this cytokine probably reflects cross-linking of their low-affinity receptors for IgE (CD23) by IgE-containing immune complexes known to give rise to monocyte activation via the NO transduction pathway. In line with this, adherent monocytic cells exposed to IgE complexes displayed increased expression of CD23. As the malaria sera contained IgG anti-IgE antibodies, such complexes probably also play a role in the induction of TNF in vivo. Overproduction of TNF is considered a major pathogenic mechanism responsible for fever and tissue lesions in P. falciparum malaria. This overproduction is generally assumed to reflect a direct stimulation of effector cells by certain parasite-derived toxins. Our results suggest that IgE elevation constitutes yet another important mechanism involved in excessive TNF induction in this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8975900      PMCID: PMC174564          DOI: 10.1128/iai.65.1.116-121.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  43 in total

1.  IgE-dependent cytokine production by human peripheral blood mononuclear phagocytes.

Authors:  L Borish; J J Mascali; L J Rosenwasser
Journal:  J Immunol       Date:  1991-01-01       Impact factor: 5.422

2.  Plasmodium-specific immunoglobulin E in sera from an area of holoendemic malaria.

Authors:  R S Desowitz
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jul-Aug       Impact factor: 2.184

3.  Regulation of Fc epsilon R2/CD23 gene expression by cytokines and specific ligands (IgE and anti-Fc epsilon R2 monoclonal antibody). Variable regulation depending on the cell types.

Authors:  T Kawabe; M Takami; M Hosoda; Y Maeda; S Sato; M Mayumi; H Mikawa; K Arai; J Yodoi
Journal:  J Immunol       Date:  1988-08-15       Impact factor: 5.422

4.  CD23 regulates monocyte activation through a novel interaction with the adhesion molecules CD11b-CD18 and CD11c-CD18.

Authors:  S Lecoanet-Henchoz; J F Gauchat; J P Aubry; P Graber; P Life; N Paul-Eugene; B Ferrua; A L Corbi; B Dugas; C Plater-Zyberk
Journal:  Immunity       Date:  1995-07       Impact factor: 31.745

5.  Inhibition of murine malaria (Plasmodium chabaudi) in vivo by recombinant interferon-gamma or tumor necrosis factor, and its enhancement by butylated hydroxyanisole.

Authors:  I A Clark; N H Hunt; G A Butcher; W B Cowden
Journal:  J Immunol       Date:  1987-11-15       Impact factor: 5.422

Review 6.  Lymphokine control of in vivo immunoglobulin isotype selection.

Authors:  F D Finkelman; J Holmes; I M Katona; J F Urban; M P Beckmann; L S Park; K A Schooley; R L Coffman; T R Mosmann; W E Paul
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

Review 7.  Anti-parasite effects of cytokines in malaria.

Authors:  K N Mendis; T D Naotunne; N D Karunaweera; G Del Giudice; G E Grau; R Carter
Journal:  Immunol Lett       Date:  1990-08       Impact factor: 3.685

Review 8.  Amplification of cytoadherence in cerebral malaria: towards a more rational explanation of disease pathophysiology.

Authors:  M Hommel
Journal:  Ann Trop Med Parasitol       Date:  1993-12

Review 9.  Malaria: toxins, cytokines and disease.

Authors:  P H Jakobsen; C A Bate; J Taverne; J H Playfair
Journal:  Parasite Immunol       Date:  1995-05       Impact factor: 2.280

10.  Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites.

Authors:  L Schofield; F Hackett
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  29 in total

1.  Genotype combinations of two IL4 polymorphisms influencing IL-4 plasma levels are associated with different risks of severe malaria in the Malian population.

Authors:  Sandrine Cabantous; Stéphane Ranque; Belco Poudiougou; Abdoulaye Traore; Sofiane Berbache; Joana Vitte; Pierre Bongrand; Ogobara Doumbo; Alain J Dessein; Laurent Abel; Sandrine Marquet
Journal:  Immunogenetics       Date:  2015-05-03       Impact factor: 2.846

2.  Impact of mosquito bites on asexual parasite density and gametocyte prevalence in asymptomatic chronic Plasmodium falciparum infections and correlation with IgE and IgG titers.

Authors:  Ramatoulaye Lawaly; Lassana Konate; Laurence Marrama; Ibrahima Dia; Diawo Diallo; Fatoumata Diène Sarr; Bradley S Schneider; Isabelle Casademont; Mawlouth Diallo; Paul T Brey; Anavaj Sakuntabhai; Salah Mecheri; Richard Paul
Journal:  Infect Immun       Date:  2012-03-26       Impact factor: 3.441

3.  Chemokine levels and parasite- and allergen-specific antibody responses in children and adults with severe or uncomplicated Plasmodium falciparum malaria.

Authors:  B Wangala; A Vovor; R G Gantin; Y F Agbeko; C J Lechner; X Huang; P T Soboslay; C Köhler
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2015-03-26

4.  Enhanced basophil reactivities during severe malaria and their relationship with the Plasmodium falciparum histamine-releasing factor translationally controlled tumor protein.

Authors:  Stéphane Pelleau; Sylvie Diop; Méry Dia Badiane; Joana Vitte; Pierre Beguin; Farida Nato; Bernard M Diop; Pierre Bongrand; Daniel Parzy; Ronan Jambou
Journal:  Infect Immun       Date:  2012-07-02       Impact factor: 3.441

5.  Immunoglobulin subclass distribution and diagnostic value of Leishmania donovani antigen-specific immunoglobulin G3 in Indian kala-azar patients.

Authors:  K Anam; F Afrin; D Banerjee; N Pramanik; S K Guha; R P Goswami; P N Gupta; S K Saha; N Ali
Journal:  Clin Diagn Lab Immunol       Date:  1999-03

6.  Development of quantitative suspension array assays for six immunoglobulin isotypes and subclasses to multiple Plasmodium falciparum antigens.

Authors:  Marta Vidal; Ruth Aguilar; Joseph J Campo; Carlota Dobaño
Journal:  J Immunol Methods       Date:  2018-01-31       Impact factor: 2.303

Review 7.  Interactions between worm infections and malaria.

Authors:  Mathieu Nacher
Journal:  Clin Rev Allergy Immunol       Date:  2004-04       Impact factor: 8.667

8.  Allelic polymorphisms in the repeat and promoter regions of the interleukin-4 gene and malaria severity in Ghanaian children.

Authors:  B A Gyan; B Goka; J T Cvetkovic; J L Kurtzhals; V Adabayeri; H Perlmann; A-K Lefvert; B D Akanmori; M Troye-Blomberg
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

9.  Increased eosinophil activity in acute Plasmodium falciparum infection--association with cerebral malaria.

Authors:  J A Kurtzhals; C M Reimert; E Tette; S K Dunyo; K A Koram; B D Akanmori; F K Nkrumah; L Hviid
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

10.  Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.

Authors:  Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Mary A Misukonis; Jocelyn R Saunders; Sri Suprianto; J Brice Weinberg; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.